155 related articles for article (PubMed ID: 19077683)
1. Relaxin and the progression of kidney disease.
Samuel CS; Hewitson TD
Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):9-14. PubMed ID: 19077683
[TBL] [Abstract][Full Text] [Related]
2. Relaxin: an endogenous renoprotective factor?
Hewitson TD; Samuel CS
Ann N Y Acad Sci; 2009 Apr; 1160():289-93. PubMed ID: 19416206
[TBL] [Abstract][Full Text] [Related]
3. Relaxin in cardiovascular and renal disease.
Samuel CS; Hewitson TD
Kidney Int; 2006 May; 69(9):1498-502. PubMed ID: 16672919
[TBL] [Abstract][Full Text] [Related]
4. Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents.
Negri AL
J Nephrol; 2004; 17(4):496-503. PubMed ID: 15372410
[TBL] [Abstract][Full Text] [Related]
5. Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.
Garber SL; Mirochnik Y; Brecklin CS; Unemori EN; Singh AK; Slobodskoy L; Grove BH; Arruda JA; Dunea G
Kidney Int; 2001 Mar; 59(3):876-82. PubMed ID: 11231342
[TBL] [Abstract][Full Text] [Related]
6. Relaxin regulates collagen overproduction associated with experimental progressive renal fibrosis.
Samuel CS; Mookerjee I; Masterson R; Tregear GW; Hewitson TD
Ann N Y Acad Sci; 2005 May; 1041():182-4. PubMed ID: 15956704
[TBL] [Abstract][Full Text] [Related]
7. Relaxin: exploring the antifibrotic potential of a pregnancy hormone.
Gaedeke J; Peters H
Kidney Int; 2005 Jul; 68(1):405-6. PubMed ID: 15954933
[No Abstract] [Full Text] [Related]
8. Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis.
Samuel CS; Zhao C; Bathgate RA; Bond CP; Burton MD; Parry LJ; Summers RJ; Tang ML; Amento EP; Tregear GW
FASEB J; 2003 Jan; 17(1):121-3. PubMed ID: 12424226
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targets for prevention and regression of progressive fibrosing renal diseases.
Eitner F; Floege J
Curr Opin Investig Drugs; 2005 Mar; 6(3):255-61. PubMed ID: 15816501
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.
Sasser JM
Am J Physiol Regul Integr Comp Physiol; 2013 Sep; 305(6):R559-65. PubMed ID: 23883673
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of kidney fibrosis and the role of antifibrotic therapies.
Deelman L; Sharma K
Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):85-90. PubMed ID: 19077695
[TBL] [Abstract][Full Text] [Related]
12. 'Relaxin' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease.
Samuel CS; Du XJ; Bathgate RA; Summers RJ
Pharmacol Ther; 2006 Nov; 112(2):529-52. PubMed ID: 16814863
[TBL] [Abstract][Full Text] [Related]
13. Relaxin: antifibrotic properties and effects in models of disease.
Samuel CS
Clin Med Res; 2005 Nov; 3(4):241-9. PubMed ID: 16303890
[TBL] [Abstract][Full Text] [Related]
14. Relaxin and its role in the development and treatment of fibrosis.
Bennett RG
Transl Res; 2009 Jul; 154(1):1-6. PubMed ID: 19524867
[TBL] [Abstract][Full Text] [Related]
15. Role of relaxin in regulation of fibrosis in the lung.
Tang ML; Samuel CS; Royce SG
Ann N Y Acad Sci; 2009 Apr; 1160():342-7. PubMed ID: 19416216
[TBL] [Abstract][Full Text] [Related]
16. Reversal of cardiac fibrosis and related dysfunction by relaxin.
Du XJ; Xu Q; Lekgabe E; Gao XM; Kiriazis H; Moore XL; Dart AM; Tregear GW; Bathgate RA; Samuel CS
Ann N Y Acad Sci; 2009 Apr; 1160():278-84. PubMed ID: 19416203
[TBL] [Abstract][Full Text] [Related]
17. Improved chemical synthesis and demonstration of the relaxin receptor binding affinity and biological activity of mouse relaxin.
Samuel CS; Lin F; Hossain MA; Zhao C; Ferraro T; Bathgate RA; Tregear GW; Wade JD
Biochemistry; 2007 May; 46(18):5374-81. PubMed ID: 17425335
[TBL] [Abstract][Full Text] [Related]
18. Relaxin ameliorates salt-sensitive hypertension and renal fibrosis.
Yoshida T; Kumagai H; Suzuki A; Kobayashi N; Ohkawa S; Odamaki M; Kohsaka T; Yamamoto T; Ikegaya N
Nephrol Dial Transplant; 2012 Jun; 27(6):2190-7. PubMed ID: 22086971
[TBL] [Abstract][Full Text] [Related]
19. Drugs of the future: the hormone relaxin.
Samuel CS; Hewitson TD; Unemori EN; Tang ML
Cell Mol Life Sci; 2007 Jun; 64(12):1539-57. PubMed ID: 17458501
[TBL] [Abstract][Full Text] [Related]
20. Investigations into the inhibitory effects of relaxin on renal myofibroblast differentiation.
Samuel CS; Mookerjee I; Halls ML; Summers RJ; Chew E; Bathgate RA; Tregear GW; Hewitson TD
Ann N Y Acad Sci; 2009 Apr; 1160():294-9. PubMed ID: 19416207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
